Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nano MRI on 7 Tesla in Rectal and Breast Cancer
NCT02751606Phase 3Unknown
- Sponsor
- Radboud University Medical Center
- Start
- Jun 2015
- Primary completion
- Jun 2019
- Modality
- Nanoparticles
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of ferumoxtran-10 in rectal cancer and breast cancer, sponsored by Radboud University Medical Center. Primary endpoint: Sensitivity and specificity of 7 Tesla MRI in combination with ferumoxtran-10 on nodal level. Status: unknown.
02
Drugs
ferumoxtran-10
03
Conditions
rectal cancerbreast cancer
Beyond the preview
Go deeper on NCT02751606.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02751606.